Science Researcher Update: Spotlight on Meetings, Conferences, and Events

Spotlight on Science Meetings, Conferences and Events brings you information on the following event: 
Webinar: Best Practices for Communicating and Interacting with FDA Reviewers

This seminar (webinar) is intended to help those in pharmaceutical and medical device industry involved in interacting and communicating with the health authorities. In particular, this seminar will discuss best practices for communicating, interacting and negotiating with FDA reviewers before and during the review process.

The speaker will guide you through the details of what is best in exercising your judgment and discretion while communicating and interacting with the FDA reviewers. In this 60-min presentation, the speaker will guide you through the details of how to implement the systematic and holistic risk management for drugs, biosimilars, biologics and medical devices.

This is an online seminar. 

Mississauga, Ontario

https://compliancetrainings.com

Monday, August 3, 2015 

 Spotlight on Science Meetings, Conferences and Events brings you information on the following event: Webinar On Selecting Right Statistical Tools to Solve Problems: August

Many pharma and biotech professionals and regulators point out that statistics is a necessary tool and yet many pharma organizations do not make proper use of the tool.

Many of the reasons for the slow adoption of statistical thinking and methods in the past are no longer relevant today (Hoerl and Snee 2012). The Internet combined with effective and easy-to-use software and new learning and application methods, have greatly broadened and increased the use and effectiveness of statistical thinking and methods. These trends and their benefits are the subject of this webinar.

Lack of use of any effective tool can often be linked to lack of understanding of the tool, the benefits of the use of the tool and how to implement the tool.

We see this when we hear questions like: “What statistical tools should my organization be using? What statistical methods do the regulators want us to use? A better approach is to identify the need, the question to be answered; then the appropriate tools are easier to identify. This approach and the associated concepts and methods involved will be introduced and illustrated with pharmaceutical and biotech case studies and examples.

This is an online seminar.

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1434

Wednesday, August 19, 2015